Patents Assigned to EWHA DrugDesignHouse Co.,Ltd.
  • INTESTINE-SPECIFIC PARTIAL AGONISTS OF FARNESOID X RECEPTOR AND USES THEREOF
    Publication number: 20230416193
    Abstract: An intestine-specific partial agonists of farnesoid X receptor (FXR) is disclosed, along with methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with FXR activity.
    Type: Application
    Filed: June 26, 2023
    Publication date: December 28, 2023
    Applicant: EWHA DrugDesignHouse Co.,Ltd.
    Inventors: Dae-Kee Kim, Soyeon Shim
  • COMPOSITION CONTAINING AN ALK5 INHIBITOR, EW-7197
    Publication number: 20230047393
    Abstract: Disclosed is a pharmaceutical composition containing EW-7197 (2-fluoro-N-((5-(6-methylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl)methyl)aniline), a pharmaceutically acceptable salt thereof, or a solvate thereof as an active ingredient useful in the treatment and prevention of a disease state mediated by transforming growth factor-? (TGF-?) type I receptor (ALK5).
    Type: Application
    Filed: August 2, 2021
    Publication date: February 16, 2023
    Applicant: EWHA DrugDesignHouse Co.,Ltd.
    Inventors: Noriaki Nishida, Dae-Kee Kim